MFMathias Fousse

Mathias Fousse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mathias Fousse has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Klaus Fassbender

    Department of Neurology Saarland University Homburg Germany

    6 shared publications
  • Dominic Kaddu-Mulindwa

    Department of Hematology and Oncology, Clinical Immunology, Rheumatology, Saarland University Medical School, Homburg, Germany

    3 shared publications
  • Klaus Fassbender

    Department of Neurology, Saarland University Medical School, Homburg, Germany

    3 shared publications
  • Martina Sester

    Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany; Center for Gender-specific Biology and Medicine (CGBM), Saarland University, Homburg, Germany

    2 shared publications
  • Matthias Heit

    Department of Hematology and Oncology, Clinical Immunology, Rheumatology, Saarland University Medical School, Homburg, Germany

    2 shared publications
  • Michael Kettner

    2 shared publications

Latest Publications

  • Open Access

    De Novo Immune Induction After COVID‐19 Vaccination Under B‐Cell Depletion Is Characterized by Robust T‐Cellular Immunity in Patients With Inflammatory Central Nervous System Disease

    by Mathias Fousse, Verena Klemis, Saskia Bronder, Rebecca Urschel, Franziska Hielscher, Klaus Faßbender, Urban Sester, Martina Sester, Tina Schmidt

    Background: Immune induction under B‐cell depletion is complex and far from being fully understood. Methods: We investigated clinical and immunological responses after dual homologous mRNA vaccination with BNT162b2 and after booster vaccination or infection in 14 B‐cell depleted patients with inflammatory central nervous system disease in comparison to 28 healthy controls. Spike‐specific IgG were determined using ELISA and neutralizing activity by surrogate assay. Reactive T cells were flow‐cytometrically analyzed after spike‐specific and polyclonal stimulation. Reactogenicity was self‐reported using a questionnaire. Results: Vaccination was well tolerated, with slightly more systemic events reported by patients. Spike‐specific antibodies were induced in all controls, but only 43% of patients with significantly lower IgG levels and reduced neutralizing capacity ( p < 0.0001). In contrast, spike‐reactive T cells were induced in both groups with similar CD4 and higher CD8 T‐cell levels in patients. Functional characterization of spike‐reactive T cells revealed equally high CTLA‐4 expression in both groups, but higher proportions of polyfunctional, triple‐cytokine expressing CD4 and CD8 T cells in patients especially after the third immunization. Three patients experienced mild breakthrough infections after second vaccination. Conclusions: Despite limited ability of B‐cell depleted patients to mount a humoral immune response after multiple doses of SARS‐CoV‐2 mRNA vaccination, the vaccine‐induced T‐cell response is robust, which may have implications for protection against severe disease.

  • Open Access

    Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin

    by Leyla Mohammad, Mathias Fousse, Gentiana Wenzel, Marina Flotats-Bastardas, Klaus Faßbender, Ulrich Dillmann, Bernhard Schick, Michael Zemlin, Barbara C. Gärtner, Urban Sester, et al.

    Background and Objectives Peripheral facial palsy (PFP) is a common neurologic symptom which can be triggered by pathogens or autoimmunity as well as trauma, tumors, cholesteatoma and further local conditions disturbing the peripheral section of the nerve. In general, its cause is often difficult to identify, remaining unknown in over two thirds of cases. As we have previously shown that the quantity and quality of pathogen-specific T cells change during active infections, we hypothesized that such changes also may help to identify the causative pathogen in PFPs of unknown origin. Methods Pathogen-specific T cells were quantified in blood samples of 55 patients with PFP and 23 healthy controls after stimulation with antigens from varicella-zoster virus (VZV), herpes-simplex viruses (HSV) or borrelia. T cells were further characterized by expression of the inhibitory surface molecule CTLA-4, and markers for differentiation (CD27) and proliferation (Ki67). Pathogen-specific antibody responses were analyzed using ELISA. Results were compared with conventional diagnostics. Results Patients with PFP were more often HSV-seropositive than controls (p=0.0003), whereas VZV-and borrelia-specific antibodies did not differ between groups. Although the quantity and general phenotypical characteristics of antigen-specific T cells did not differ either, expression of CTLA-4 and Ki67 was highly increased in VZV-specific T cells of 9 PFP patients, of which 5 showed typical signs of cutaneous zoster. In the remaining 4 patients, a causal relationship with VZV was possible but remained unclear by clinical standard diagnostics. A similar CTLA-4- and Ki67-expression profile was also found in a patient with acute neuroborreliosis. Discussion In conclusion, the high prevalence of HSV-seropositivity among PFP-patients may indicate an underestimation of HSV-involvement in PFP, even though HSV-specific T-cell characteristics seem insufficient to identify HSV as a causative agent. In contrast, striking alterations in VZV- and borrelia-specific T-cell phenotype and function may allow identification of VZV- and borrelia-triggered PFPs thus bearing the potential to improve specificity of the clinical diagnosis.

  • Open Access

    Is It Lupus? Is It Neuromyelitis Optica Spectrum Disorder (NMOSD)?—Why Not Both?

    by Niklas Alexander Kaempfer, Mathias Fousse, Michael Kettner, Klaus Fassbender, Daniel Janitschke

    Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are among the commonly considered differential diagnoses in patients with inflammatory central nervous system (CNS)-diseases. Formerly diagnosed competing autoimmune diseases might impair diagnostics and treatment. Here, we report on a 41-year-old woman admitted to our hospital with primary manifestation of NMOSD (paresthesia, paralysis of the lower extremities, and urinary incontinence) while undergoing treatment for a diagnosed systemic lupus erythematosus (SLE) with hydroxychloroquine. CNS manifestation of the disease was considered. Magnetic resonance imaging (MRI) of the cranium and spinal cord showed multiple supratentorial lesions of the white matter and massive intramedullary lesions with contrast enhancement. Cerebrospinal fluid (CSF) showed pleocytosis (20/µL), positive antinuclear antibodies (ANA), antiphospholipid antibodies, and SSA/Ro antibodies, while formerly positive dsDNA antibodies were negative. Further diagnostics revealed a 1:10,240 serum titer of Aquaporine-4 antibodies. The patient received intravenous methylprednisolone for three days (2 g per day), which led to an escalation to plasmapheresis and to an improved EDSS from 8.0 to 4.0. Because of the comorbidity, a combined relapse prophylaxis with satralizumab and mycophenolate mofetil was established. Rehabilitation and continued treatment improved EDSS to 1.0 with no impairment of mobilization. Although formerly diagnosed SLE could have explained the symptoms, it is important to reconsider competitive diseases in order to establish adequate immunotherapy.


  • Open Access

    Neurologic Consultations and Headache during Pregnancy and in Puerperium: A Retrospective Chart Review

    by Julia S. M. Zimmermann, Mathias Fousse, Ingolf Juhasz-Böss, Julia C. Radosa, Erich-Franz Solomayer, Ruben Mühl-Benninghaus

    Headache is a common symptom during pregnancy and in puerperium that requires careful consideration, as it may be caused by a life-threatening condition. Headaches in pregnant women and women in puerperium are classified as primary or secondary; acute, severe and newly diagnosed headaches should prompt further investigation. We aimed to further characterise the demographic features, symptoms, examination findings, and neuroimaging results of cases of headache during pregnancy and in puerperium. All pregnant women or women in postpartum conditions who attended neurological consultations at the emergency department of the clinic for Gynaecology, Obstetrics and Reproductive Medicine of Saarland University/Germany between 2001/2015 and 2012/2019 were enrolled in this retrospective chart review. Data collected from the charts included demographic/pregnancy characteristics, clinical features and imaging findings. Descriptive statistics as well as binary logistic regression were performed. More than 50% of 97 patients had abnormal findings in their neurological examination. Magnetic resonance imaging findings were pathological for almost 20% of patients—indicating conditions such as cerebral venous thrombosis, reversible posterior leukoencephalopathy, brain tumour and intracranial bleeding. The odds of abnormal neuroimaging results were 2.2-times greater among women with abnormal neurological examination findings than among those with normal examination results. In cases of headache during pregnancy and in puerperium, neuroimaging should be indicated early on. Further research is needed to determine which conditions indicate a need for immediate neuroimaging.


  • Open Access

    Identification of Neural Mechanisms in First Single-Sweep Analysis in oVEMPs and Novel Normative Data

    by Dietmar J. Hecker, Hans Scherer, Uwe Schönfeld, Laura Jerono, Armand Koch, Anna-Katharina Rink, Lisa Schulte-Goebel, Maximilian Linxweiler, Mathias Fousse, Alessandro Bozzato, et al.

    Background: Bone-conducted (BC) VEMPs provide important tools for measuring otolith function. However, two major drawbacks of this method are encountered in clinical practice—small n10 amplitude and averaging technique. In this study, we present the results of a new VEMP setup measuring technique combined with a novel single-sweep analysis. Methods: The study included BC oVEMP data from 92 participants for the evaluation of normative data using a novel analysis technique. For evaluating test-retest reliability, the intraclass correlation coefficient (ICC) was used. Results: We found significant n10 amplitude differences in single-sweep analyses after the first and second measurements. Thereby, mathematical analyses of the head movement did not show any differences in the first or second measurements. The normative n10 amplitude was 20.66 µV with an asymmetric ratio (AR) of 7%. The new value of late shift difference (LSD) was 0.01 ms. The test retest-reliability showed good to excellent ICC results in 9 out of 10 measurements. Conclusions: Our results support a phenomenon in single-sweep analysis of the first stimuli independent of head movement and signal morphology. Furthermore, the values obtained with the new measurement method appear to be more sensitive and may allow an extended diagnostic range due to the new parameter LSD.


  • Open Access

    Fewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysis

    by Dominic Kaddu-Mulindwa, Matthias Heit, Gudrun Wagenpfeil, Moritz Bewarder, Klaus Fassbender, Stefanie Behnke, Umut Yilmaz, Mathias Fousse

    Background: Despite antiretroviral therapy, cognitive dysfunction seems to remain a major issue for people living with human immunodeficiency virus (PLWH). Previous studies showed a correlation between the width of the third ventricle (WTV) and neurocognitive disorders in PLWH.Patients and methods: We investigated prevalence and correlation of neuropsychological disorders using WTV as a brain atrophy marker examined by transcranial sonography and MRI in PLWH and healthy age- and gender-matched controls. We used Becks Depression Inventory (BDI) for depression screening, the questionnaires Fatigue Severity Scale (FSS) for fatigue and Short-Form-36 (SF36) for quality of life (QoL) evaluation and Consortium to establish a registry for Alzheimer's disease (CERAD-PLUS) as neuropsychological test battery.Results: 52 PLWH (47 males) and 28 non-infected controls (23 males) with a median age of 52 years (24–78 years) and 51 years (22–79) were analyzed. WTV correlated significantly with age (p < 0.01) but showed no significantly difference in PLWH (median = 3.4 mm) compared to healthy controls (median = 2.8 mm) (p = 0.085). PLWH had both significantly higher BDI-Scores (p = 0.005) and FSS-Scores (p = 0.012). Controls reported higher QoL (SF-36) with significant differences in most items. However, the overall cognitive performance (CERAD total score) showed no significant difference. The WTV of all subjects correlated with neurocognitive performance measured as CERAD total score (p = 0.009) and trail making tests A (p < 0.001) and B (p = 0.018). There was no correlation between the scores of BDI, FSS, SF-36, and CERAD-PLUS items and WTV.Conclusion: WTV is considered as a predictor of cognitive deficits in neurodegenerative diseases. Nevertheless, we found no significant difference in WTV or overall cognitive performance between PLWH and controls. PLWH suffer more often from depression and fatigue and report reduced QoL when compared to healthy controls.


  • Open Access

    Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination

    by Mathias Fousse, David Schub, Fatma Merzou, Klaus Fassbender, Martina Sester, Michael Kettner, Piergiorgio Lochner, Tina Schmidt, João Reinoldo Goi Júnior

    SARS-CoV-2 infection is associated with an increased rate of thromboembolic events and mortality. Different vaccines are globally used to limit the pandemic. In this report, we present the case of two young female patients with newly diagnosed cerebral sinus vein thrombosis occurring after injection of the vector-based ChAdOx1 vaccine. Both patients presented with unusual headache only. The two of them used an estrogen-containing contraception, had had a history of deep venous thrombosis, and both had MTHFR mutations. Both patients developed SARS-CoV-2 specific humoral and cellular immunity including both CD4 and CD8 T cells. This rare, but serious complication needs to be considered after vaccination of young females, even if there is no evidence of heparin-induced thrombocytopenia.


  • Intravenous thrombolysis with tPA and cortical involvement increase the risk of early poststroke seizures: Results of a case–control study

    by Francesco Brigo, Maximilian Schneider, Gudrun Wagenpfeil, Andreas Ragoschke-Schumm, Mathias Fousse, Claudia Holzhoffer, Raffaele Nardone, Klaus Faßbender, Piergiorgio Lochner